Evidence map›Paper›PMID 42288930›Full record

ArticleJournal of medical case reports2026

Neurodegenerative decline following a mild traumatic brain injury: a case report.

Melanie A Mason, James Geiselman, Shawn Spooner

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Melanie A MasonDepartment of Health and Movement Science, Graceland University, Lamoni, IA, USA. mason6@graceland.edu.ORCID http://orcid.org/0009-0001-0747-3332
James GeiselmanDepartment of Health and Movement Science, Graceland University, Lamoni, IA, USA.
Shawn SpoonerSports Medicine, UnityPoint Clinic Sports Medicine and Concussion Center, Urbandale, IA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA growing body of research suggests that mild traumatic brain injury (mTBI) increases the chance of developing neurodegenerative disease in adults. Elderly patients are of great concern due to an increased risk of head injury due to falls. CASE REPORT: The patient was a 71-year-old White, non-Hispanic female who fell from a ladder and suffered an initially undiagnosed mild traumatic brain injury (mTBI). Seventeen months after injury, she was evaluated by a concussion specialist who retrospectively diagnosed mTBI. Subsequent neuropsychological evaluation resulted in a diagnosis of probable Lewy body dementia. The patient experienced rapid neurological decline and died thirty-three months after the initial fall.

conclusionsMild traumatic brain injury (mTBI) and its persisting symptoms are frequently misdiagnosed, often leading to symptom-based overmedication and lack of appropriate targeted treatment. This highlights the need for advanced training for providers on mTBI and the potential for persisting symptoms associated with it. Providers also need to understand the risk of neurological decline following mTBI, especially in the elderly population. Clinicians should not rely exclusively on patient self-report for diagnosis and treatment of mTBI and should use a multidisciplinary approach. In addition, disparities in rural access to specialized care must be addressed to ensure equitable post-injury outcomes.

Indexed as

Brain ConcussionLewy Body DiseaseAccidental FallsAgedFatal OutcomeFemaleHumansNeuropsychological TestsConcussionElderlyLewy body dementiamTBINeurodegenerative decline

Identifiers

PMID42288930
PMCPMC13386556

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.